{"id":203571,"date":"2025-12-24T00:00:00","date_gmt":"2025-12-24T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041146-medtech-peripheral-vascular-devices-market-insights\/"},"modified":"2026-04-23T11:01:56","modified_gmt":"2026-04-23T11:01:56","slug":"47042550-medtech-peripheral-vascular-devices-market-insights-europe","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042550-medtech-peripheral-vascular-devices-market-insights-europe\/","title":{"rendered":"Peripheral Vascular Devices &#8211; Market Insights &#8211; Europe"},"content":{"rendered":"<p>The European <abbr title=\"Peripheral Vascular\">PV<\/abbr> device market will be mainly driven by the increasing availability of premium-priced products and emerging products which, supported by clinical data, will increase the penetration of endovascular techniques, especially for the revascularization of the iliac and lower-limb arteries. Nevertheless, market growth will be limited to some extent by price competition, unfavorable reimbursement, and unwillingness to some clinicians to adopt new technologies.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the market for <abbr title=\"Peripheral Vascular\">PV<\/abbr> devices in Europe from 2019 through 2034.<\/p>\n<p><strong>Uptake of premium-priced devices and emerging products will drive growth in the market.<\/strong><\/p>\n<p>Which markets will show the highest growth rates in Europe?<\/p>\n<p>To what degree will <abbr title=\"Drug-Eluting Stent(s)\">DES<\/abbr> and <abbr title=\"Drug-Coated Balloon\">DCB<\/abbr>s be adopted in Europe over the forecast period?<\/p>\n<p>What is the future outlook for the adoption of covered <abbr title=\"Self-Expandable\">SX<\/abbr> and <abbr title=\"Balloon-Expandable\">BX<\/abbr> stents?<\/p>\n<p>How readily have <abbr title=\"Intravascular Lithotripsy\">IVL<\/abbr> procedures been adopted for <abbr title=\"Peripheral Vascular\">PV<\/abbr> indications? Are new devices expected to enter the market?<\/p>\n<p>To what extent will recently launched <abbr title=\"Bioresorbable Scaffold(s)\">BRS<\/abbr> be adopted?<\/p>\n<p>What impact will these trends have on the competitive landscape?<\/p>\n<p><strong>The generation of clinical evidence is key to driving adoption of new technologies.<\/strong><\/p>\n<p>Which devices have shown the most positive outcomes?<\/p>\n<p>Which are the most relevant clinical trials that are currently ongoing?<\/p>\n<p>What impact have head-to-head trials had on physicians\u2019 device preferences?<\/p>\n<p><strong>Procedure volume growth will be driven by greater adoption of interventional endovascular techniques for <abbr abbreviation-entity-id=\"9160\" data-display-abbreviation=\"Infrapop\" title=\"Infrapopliteal\">infrapop<\/abbr>\u00a0(<abbr title=\"Below-the-Knee\">BTK<\/abbr>) artery revascularization.<\/strong><\/p>\n<p>How will product innovation contribute to procedure volume growth?<\/p>\n<p>Which devices are likely to see the greatest uptake?<\/p>\n<p>How does this trend affect the <abbr title=\"Peripheral Vascular\">PV<\/abbr> device market?<\/p>\n<p><b>Merger and acquisition activities or partnerships involving key competitors may lead to shifts in market shares going forward.<\/b><\/p>\n<p>Which acquisitions have occurred, and how will these acquisitions impact competitor performance in the future?<\/p>\n<p>How are competitors leveraging product portfolio acquisitions to expand their product offerings?<\/p>\n","protected":false},"template":"","class_list":["post-203571","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-therapy-area-peripheral-vascular-devices","medtech-geography-europe","medtech-date-2294"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/203571","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":10,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/203571\/revisions"}],"predecessor-version":[{"id":575093,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/203571\/revisions\/575093"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=203571"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}